Key Drivers
- Low profitability
- Large insurance liabilities
- Strong investment assets
AIAI Summary
Genworth's investment thesis has shifted to a two‑pillar story where Enact's monetizable cash flows must reliably fund buybacks and buy time for CareScout to scale, so investors should track Enact's quarterly transfer/monetization cadence, CareScout commercialization milestones, and the binary AXA/litigation and LTC reserve trends that will determine whether the deep P/B discount re-rates or downside accelerates.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Low profitability
- •Large insurance liabilities
- •Strong investment assets
Genworth is an asset-rich, low‑leverage insurer trading well below tangible book with weak profitability and pronounced quarterly earnings volatility that raises sustainability risk.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Below short-term MA
- •Support tested
Over the last month the stock fell roughly 9% from $8.78 to $7.99, trading about 4% below its short-term average and showing a short-term downtrend with support near $7.94 and resistance around $8.55–$8.78.
Gradual ~9% decline from $8.78 to $7.99 over last month with modest intraperiod rebounds
Sentiment & News
Key News Insights:
- •CareScout expansion
- •New consumer plans
- •Large institutional sale
Genworth reported strong execution in 2025 with CareScout expansion and new consumer Care Plans, while Citigroup cut its stake by 61% in March.
Operational momentum in CareScout should support growth narratives, but the sizable Citigroup stake reduction may weigh on near-term investor sentiment
Similar Companies in Financial Services
Other companies in the same sector with AI ratings